John E. Wagner

35.7k total citations · 8 hit papers
407 papers, 24.1k citations indexed

About

John E. Wagner is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, John E. Wagner has authored 407 papers receiving a total of 24.1k indexed citations (citations by other indexed papers that have themselves been cited), including 299 papers in Hematology, 117 papers in Oncology and 93 papers in Immunology. Recurrent topics in John E. Wagner's work include Hematopoietic Stem Cell Transplantation (284 papers), Polyomavirus and related diseases (82 papers) and Acute Myeloid Leukemia Research (71 papers). John E. Wagner is often cited by papers focused on Hematopoietic Stem Cell Transplantation (284 papers), Polyomavirus and related diseases (82 papers) and Acute Myeloid Leukemia Research (71 papers). John E. Wagner collaborates with scholars based in United States, United Kingdom and France. John E. Wagner's co-authors include Todd E. DeFor, Bruce R. Blazar, Daniel J. Weisdorf, Juliet N. Barker, Claudio G. Brunstein, Jeffrey S. Miller, Margaret L. MacMillan, Philip B. McGlave, Stella M. Davies and Mary M. Horowitz and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

John E. Wagner

390 papers receiving 23.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

2005 1.4k citations Jeffrey S. Miller, David H. McKenna et al. Blood profile →
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

2010 805 citations Claudio G. Brunstein, Jeffrey S. Miller et al. Blood profile →
Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia

2004 783 citations Pablo Rubinstein, John E. Wagner et al. New England Journal of Medicine profile →
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

2002 743 citations John E. Wagner, Juliet N. Barker et al. Blood profile →
Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors

2001 643 citations Juliet N. Barker, John E. Wagner et al. New England Journal of Medicine profile →
Graft-Versus-Host Disease in Children Who Have Received a Cord-Blood or Bone Marrow Transplant from an HLA-Identical Sibling

2000 623 citations John E. Wagner, Éliane Gluckman et al. New England Journal of Medicine profile →
Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

2004 597 citations Juliet N. Barker, Daniel J. Weisdorf et al. Blood profile →
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study

2007 557 citations Pablo Rubinstein, Joanne Kurtzberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John E. Wagner United States	79	15.8k	8.7k	6.2k	6.1k	3.8k	407	24.1k
Andrea Bacigalupo Italy	83	18.3k 1.2×	6.6k 0.8×	6.7k 1.1×	6.8k 1.1×	2.5k 0.7×	592	26.3k
Francesco Frassoni Italy	60	9.7k 0.6×	5.5k 0.6×	4.0k 0.6×	7.3k 1.2×	2.9k 0.8×	327	18.5k
Elizabeth J. Shpall United States	73	8.7k 0.6×	5.9k 0.7×	8.9k 1.4×	3.9k 0.6×	4.7k 1.2×	621	21.0k
Rupert Handgretinger Germany	70	6.4k 0.4×	7.0k 0.8×	5.4k 0.9×	2.2k 0.4×	5.3k 1.4×	493	19.0k
Lothar Kanz Germany	83	6.3k 0.4×	6.3k 0.7×	6.6k 1.1×	3.4k 0.6×	5.8k 1.5×	579	22.1k
Roel Willemze Netherlands	59	7.3k 0.5×	5.4k 0.6×	3.9k 0.6×	3.3k 0.5×	3.4k 0.9×	288	14.3k
Mitchell S. Cairo United States	61	4.8k 0.3×	3.0k 0.3×	4.5k 0.7×	2.6k 0.4×	2.7k 0.7×	507	14.9k
Helmut Gadner Austria	73	6.5k 0.4×	2.9k 0.3×	3.9k 0.6×	1.3k 0.2×	2.9k 0.8×	408	20.4k
Dario Campana United States	85	9.1k 0.6×	7.7k 0.9×	7.6k 1.2×	2.5k 0.4×	5.2k 1.4×	287	22.5k
Robert S. Negrin United States	71	6.9k 0.4×	10.2k 1.2×	6.0k 1.0×	1.9k 0.3×	3.3k 0.9×	307	18.0k

Countries citing papers authored by John E. Wagner

Since Specialization

Citations

This map shows the geographic impact of John E. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Wagner more than expected).

Fields of papers citing papers by John E. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Wagner. The network helps show where John E. Wagner may publish in the future.

Co-authorship network of co-authors of John E. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Wagner. A scholar is included among the top collaborators of John E. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Wagner. John E. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ebens, Christen L., et al.. (2017). Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia. Biology of Blood and Marrow Transplantation. 24(4). 765–771. 27 indexed citations

Osborn, Mark J., Cara-lin Lonetree, Beau R. Webber, et al.. (2016). CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia. Stem Cells and Development. 25(20). 1591–1603. 26 indexed citations

Brunstein, Claudio G., Jeffrey S. Miller, David H. McKenna, et al.. (2015). Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. Blood. 127(8). 1044–1051. 303 indexed citations

MacMillan, Margaret L., Todd E. DeFor, Jo‐Anne H. Young, et al.. (2015). Alternative donor hematopoietic cell transplantation for Fanconi anemia. Blood. 125(24). 3798–3804. 66 indexed citations

Osborn, Mark J., Richard Gabriel, Beau R. Webber, et al.. (2014). Fanconi Anemia Gene Editing by the CRISPR/Cas9 System. Human Gene Therapy. 26(2). 114–126. 91 indexed citations

Wood, Deborah, Robin L. Wesselschmidt, Peiman Hematti, et al.. (2014). An Update from the United States National Heart, Lung, and Blood Institute‐funded Production Assistance for Cellular Therapies (PACT) Program: A Decade of Cell Therapy. Clinical and Translational Science. 7(2). 93–99. 5 indexed citations

Üstün, Celalettin, Jiří Slabý, Ryan Shanley, et al.. (2012). Human Parainfluenza Virus Infection after Hematopoietic Stem Cell Transplantation: Risk Factors, Management, Mortality, and Changes over Time. Biology of Blood and Marrow Transplantation. 18(10). 1580–1588. 49 indexed citations

Orchard, Paul J. & John E. Wagner. (2011). Leukodystrophy and Gene Therapy with a Dimmer Switch. New England Journal of Medicine. 364(6). 572–573. 9 indexed citations

Johnson, L’Aurelle A., Bhaskar Malayappan, Natalia Tretyakova, et al.. (2011). Formation of cyclophosphamide specific DNA adducts in hematological diseases. Pediatric Blood & Cancer. 58(5). 708–714. 33 indexed citations

10.

Brunstein, Claudio G., Jeffrey S. Miller, Qing Cao, et al.. (2010). Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 117(3). 1061–1070. 805 indexed citations breakdown →

11.

Brunstein, Claudio G., Jonathan A. Gutman, Daniel J. Weisdorf, et al.. (2010). Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood. 116(22). 4693–4699. 311 indexed citations

12.

Tolar, Jakub, Akemi Ishida‐Yamamoto, Megan Riddle, et al.. (2008). Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood. 113(5). 1167–1174. 125 indexed citations

13.

Kurtzberg, Joanne, Vinod K. Prasad, Shelly L. Carter, et al.. (2008). Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood. 112(10). 4318–4327. 223 indexed citations

14.

Brunstein, Claudio G., Juliet N. Barker, Daniel J. Weisdorf, et al.. (2007). Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood. 110(8). 3064–3070. 376 indexed citations

15.

Wagner, John E., Richard Champlin, & Lawrence D. Petz. (2005). Symposium Summary. Biology of Blood and Marrow Transplantation. 11(11). 921–927. 1 indexed citations

16.

Vallera, Daniel A., Michael K. Elson, Martin W. Brechbiel, et al.. (2004). Radiotherapy of CD19 Expressing Daudi Tumors in Nude Mice with Yttrium-90-Labeled Anti-CD19 Antibody. Cancer Biotherapy and Radiopharmaceuticals. 19(1). 11–23. 14 indexed citations

17.

MacMillan, Margaret L., Daniel J. Weisdorf, John E. Wagner, et al.. (2002). Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems. Biology of Blood and Marrow Transplantation. 8(7). 387–394. 297 indexed citations

18.

Fraser, John K., Mitchell S. Cairo, Elizabeth L. Wagner, et al.. (1998). Cord Blood Transplantation Study (COBLT): Cord Blood Bank Standard Operating Procedures. Journal of Hematotherapy. 7(6). 521–561. 84 indexed citations

19.

Broxmeyer, Hal E., E Gluckman, Anver Kuliev, et al.. (1998). Cord blood banking. Bulletin of the World Health Organization. 76(3). 313–316. 1 indexed citations

20.

Gluckman, Éliane, John E. Wagner, J. Hows, et al.. (1993). Cord blood banking for hematopoietic stem cell transplantation: an international cord blood transplant registry.. PubMed. 11(3). 199–200. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact